Swedish Orphan Biovitrum AB (publ)
STO:SOBI
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Swedish Orphan Biovitrum AB (publ)
Intangible Assets
Swedish Orphan Biovitrum AB (publ)
Intangible Assets Peer Comparison
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Intangible Assets
kr50.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
28%
|
|
Biogaia AB
STO:BIOG B
|
Intangible Assets
kr46.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Hansa Biopharma AB
STO:HNSA
|
Intangible Assets
kr147.5m
|
CAGR 3-Years
68%
|
CAGR 5-Years
35%
|
CAGR 10-Years
15%
|
|
Bonesupport Holding AB
STO:BONEX
|
Intangible Assets
kr13.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Vitrolife AB
STO:VITR
|
Intangible Assets
kr4.4B
|
CAGR 3-Years
146%
|
CAGR 5-Years
72%
|
CAGR 10-Years
72%
|
|
BioArctic AB
STO:BIOA B
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Swedish Orphan Biovitrum AB (publ)'s Intangible Assets?
Intangible Assets
50.9B
SEK
Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Intangible Assets amounts to 50.9B SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Intangible Assets growth rate?
Intangible Assets CAGR 10Y
28%
Over the last year, the Intangible Assets growth was 44%. The average annual Intangible Assets growth rates for Swedish Orphan Biovitrum AB (publ) have been 16% over the past three years , 18% over the past five years , and 28% over the past ten years .